Skip to content

Clinical trials

Completed Pulmonary Disease, Chronic Obstructive trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Status: Completed Country / region: Bulgaria Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20054
20062
20071
20084
20093
20106
20118
20127
20135
20147
20155
20162
20173
20182
20193
20204
20212
20226
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca26
GlaxoSmithKline12
Chiesi Farmaceutici S.p.A.8
Novartis Pharmaceuticals7
Boehringer Ingelheim6
Sanofi5
Pfizer3
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA3
MedImmune LLC2
Mereo BioPharma2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive81
Lung Diseases5
Asthma3
Emphysema3
Lung Diseases, Obstructive3
Respiration Disorders3
Bronchiolitis Obliterans Syndrome2
Respiratory Tract Diseases2
Bronchial Diseases1
Bronchitis1

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.